Literature DB >> 27299797

MAML2 Status in Mucoepidermoid Carcinoma Can No Longer Be Considered a Prognostic Marker.

Raja R Seethala1, Simion I Chiosea.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27299797     DOI： 10.1097/PAS.0000000000000676

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN： 0147-5185            Impact factor:   6.394


× No keyword cloud information.
  10 in total

1.  MAML2 Rearrangements in Variant Forms of Mucoepidermoid Carcinoma: Ancillary Diagnostic Testing for the Ciliated and Warthin-like Variants.

Authors:  Justin A Bishop; Morgan L Cowan; Chung H Shum; William H Westra
Journal:  Am J Surg Pathol       Date:  2018-01       Impact factor: 6.394

2.  CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibition.

Authors:  Adele M Musicant; Kshitij Parag-Sharma; Weida Gong; Monideepa Sengupta; Arindam Chatterjee; Erin C Henry; Yi-Hsuan Tsai; Michele C Hayward; Siddharth Sheth; Renee Betancourt; Trevor G Hackman; Ricardo J Padilla; Joel S Parker; Jimena Giudice; Colin A Flaveny; David N Hayes; Antonio L Amelio
Journal:  Cell Rep       Date:  2021-02-23       Impact factor: 9.423

3.  Diagnostic discrepancy in second opinion reviews of primary epithelial neoplasms involving salivary gland: An 11-year experience from a tertiary referral center focusing on useful pathologic approaches and potential clinical impacts.

Authors:  Bin Xu; Ronald Ghossein; Alan Ho; Kartik Viswanathan; Anjanie Khimraj; Maelle Saliba; Jennifer R Cracchiolo; Nora Katabi
Journal:  Head Neck       Date:  2021-04-24       Impact factor: 3.821

4.  Mucoepidermoid carcinoma of the sublingual gland harboring a translocation of the MAML2 gene: A case report.

Authors:  Kiminobu Sato; Jun Akiba; Ken Nakamura; Hideyuki Abe; Akihiko Kawahara; Takeichiro Aso; Hirohito Umeno; Hiroshi Harada; Hirohisa Yano
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

5.  Intra-Cystic (In Situ) Mucoepidermoid Carcinoma: A Clinico-Pathological Study of 14 Cases.

Authors:  Saverio Capodiferro; Giuseppe Ingravallo; Luisa Limongelli; Mauro Giuseppe Mastropasqua; Angela Tempesta; Gianfranco Favia; Eugenio Maiorano
Journal:  J Clin Med       Date:  2020-04-18       Impact factor: 4.241

6.  miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands.

Authors:  Erika Naakka; Mateus Camargo Barros-Filho; Shady Adnan-Awad; Ahmed Al-Samadi; Fábio Albuquerque Marchi; Hellen Kuasne; Katja Korelin; Ilida Suleymanova; Amy Louise Brown; Cristovam Scapulatempo-Neto; Silvia Vanessa Lourenço; Rogério Moraes Castilho; Luiz Paulo Kowalski; Antti Mäkitie; Vera Cavalcanti Araújo; Ilmo Leivo; Silvia Regina Rogatto; Tuula Salo; Fabricio Passador-Santos
Journal:  Front Oncol       Date:  2022-02-09       Impact factor: 6.244

7.  MAML2-Rearranged Mucoepidermoid Carcinoma of the Parotid Gland: A Report in a 20-Month-Old Toddler.

Authors:  Adepitan A Owosho; Abiodun S Olatunji; Adewale F Adejobi; Olawumi A Fatusi; Toluwaniyin Okunade; Kelly Maddux; Justin Shaw; Kurt F Summersgill
Journal:  Case Rep Dent       Date:  2022-03-29

8.  Expression of Mucins in Salivary Gland Mucoepidermoid Carcinoma.

Authors:  Liam Robinson; Marlene B van Heerden; Jason G Ker-Fox; Keith D Hunter; Willie F P van Heerden
Journal:  Head Neck Pathol       Date:  2020-09-21

9.  Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.

Authors:  Yoshihide Okumura; Satsuki Nakano; Takayuki Murase; Kaori Ueda; Daisuke Kawakita; Toshitaka Nagao; Kimihide Kusafuka; Makoto Urano; Hidetaka Yamamoto; Satoshi Kano; Kiyoaki Tsukahara; Kenji Okami; Toru Nagao; Nobuhiro Hanai; Hiroshi Iwai; Ryo Kawata; Yuichiro Tada; Ken-Ichi Nibu; Hiroshi Inagaki
Journal:  Cancer Sci       Date:  2020-09-14       Impact factor: 6.716

10.  Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping.

Authors:  André Fehr; Sarah Werenicz; Pietro Trocchi; Markus Falk; Reinhard E Friedrich; Angelika Stammler; Andreas Stang; Florian Oesterling; Laura Khil; Göran Stenman; Werner Böcker; Katharina Tiemann; Thomas Löning
Journal:  Virchows Arch       Date:  2021-07-07       Impact factor: 4.064
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.